HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Livia Pisciotta Selected Research

Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)

10/2021Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.
2/2012Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
9/2005Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Livia Pisciotta Research Topics

Disease

12Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2020 - 05/2002
9Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 04/2005
7Hypercholesterolemia
06/2020 - 09/2005
6Dyslipidemias (Dyslipidemia)
10/2021 - 05/2008
6Atherosclerosis
02/2020 - 04/2005
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 11/2015
5Coronary Artery Disease (Coronary Atherosclerosis)
07/2020 - 04/2003
4Wolman Disease (Wolman's Disease)
10/2021 - 03/2012
4Homozygous Familial Hypercholesterolemia
01/2021 - 10/2006
4Coronary Disease (Coronary Heart Disease)
07/2020 - 06/2006
4Hypertension (High Blood Pressure)
08/2019 - 05/2004
4Xanthomatosis (Xanthoma)
01/2017 - 04/2003
4Hypertriglyceridemia
11/2015 - 02/2005
4Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
11/2015 - 06/2004
4Hyperlipidemias (Hyperlipidemia)
01/2015 - 06/2009
3Carotid Artery Diseases
01/2022 - 06/2006
3Ataxia (Dyssynergia)
12/2021 - 01/2018
3Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
10/2021 - 09/2005
3Cholesterol Ester Storage Disease
01/2018 - 06/2009
3Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2016 - 10/2006
2Fatty Liver
10/2021 - 01/2018
2Intellectual Disability (Idiocy)
01/2021 - 09/2019
2Hypobetalipoproteinemias (Hypobetalipoproteinemia)
11/2019 - 02/2012
2Hepatomegaly
10/2017 - 06/2009
2Thalassemia
11/2015 - 08/2004
2Tangier Disease
04/2010 - 02/2003
2Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
05/2008 - 02/2005
1Non-alcoholic Fatty Liver Disease
10/2021
1Hyperlipoproteinemia Type V
10/2021
1Cerebellar Ataxia (Dysmetria)
02/2021
1COVID-19
01/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021
1Movement Disorders (Movement Disorder)
01/2021
1Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2020
1Pancreatitis
12/2019
1Spasm (Spasms)
10/2019
1Brain Diseases (Brain Disorder)
10/2019
1Seizures (Absence Seizure)
10/2019
1ATR-X syndrome
10/2019
1Inflammation (Inflammations)
08/2019
1CAPOS syndrome
03/2018
1Carotid Stenosis (Carotid Artery Stenosis)
03/2018
1Alternating hemiplegia of childhood
03/2018
1Dystonia 12
03/2018
1Acute Coronary Syndrome
03/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2018

Drug/Important Bio-Agent (IBA)

15oxidized low density lipoproteinIBA
01/2021 - 04/2003
13LDL CholesterolIBA
06/2020 - 08/2004
12LipidsIBA
10/2021 - 05/2006
9CholesterolIBA
07/2020 - 02/2005
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2020 - 02/2005
7Lipoproteins (Lipoprotein)IBA
01/2021 - 09/2005
7LDL Receptors (LDL Receptor)IBA
09/2012 - 05/2002
6Triglycerides (Triacylglycerol)IBA
01/2016 - 02/2005
5EnzymesIBA
01/2021 - 05/2006
5LDL Lipoproteins (beta Lipoproteins)IBA
01/2016 - 08/2004
5HDL CholesterolIBA
01/2016 - 02/2012
4Lipoprotein(a)IBA
01/2022 - 01/2016
4ApolipoproteinsIBA
11/2019 - 02/2012
3ADP-ribosylarginine hydrolaseIBA
12/2021 - 01/2018
3Lipase (Acid Lipase)FDA Link
10/2021 - 06/2009
3PCSK9 InhibitorsIBA
02/2020 - 01/2016
3Ezetimibe (Zetia)FDA Link
01/2020 - 09/2012
3Apolipoproteins B (ApoB)IBA
11/2019 - 06/2006
3Nonsense Codon (Nonsense Mutation)IBA
09/2019 - 04/2003
3HDL LipoproteinsIBA
07/2017 - 06/2009
3Apolipoprotein A-I (Apolipoprotein A1)IBA
11/2015 - 04/2003
2Transaminases (Aminotransferases)IBA
10/2021 - 10/2017
2BMS201038IBA
01/2021 - 07/2017
2Apolipoproteins AIBA
07/2020 - 02/2005
2Monoclonal AntibodiesIBA
01/2020 - 01/2016
2Pharmaceutical PreparationsIBA
10/2019 - 07/2017
2Antihypertensive Agents (Antihypertensives)IBA
08/2019 - 01/2013
2Proprotein Convertase 9IBA
07/2017 - 01/2016
2alirocumabIBA
07/2017 - 01/2016
2Apolipoprotein C-II (ApoC2)IBA
11/2015 - 02/2005
2Apolipoproteins E (ApoE)IBA
03/2013 - 01/2013
2Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA
05/2006 - 06/2004
1AcidsIBA
10/2021
1OsteopontinIBA
03/2021
1coenzyme Q10 (CoQ10)IBA
02/2021
1Phosphotransferases (Kinase)IBA
02/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
1Serotonin (5 Hydroxytryptamine)IBA
01/2021
1Tryptophan HydroxylaseIBA
01/2021
1FlunarizineIBA
01/2021
1Protein Isoforms (Isoforms)IBA
07/2020
1C-Reactive ProteinIBA
08/2019
1Rosuvastatin Calcium (Crestor)FDA Link
03/2018
1Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
03/2018
1InflammasomesIBA
01/2018

Therapy/Procedure

6Therapeutics
01/2021 - 09/2012
4Blood Component Removal (Apheresis)
01/2021 - 07/2017
2Drug Therapy (Chemotherapy)
07/2017 - 01/2015
1Mediterranean Diet
04/2021
1Noninvasive Ventilation
01/2021
1Ketogenic Diet
01/2021
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
11/2020
1Endarterectomy (Thromboendarterectomy)
03/2018